- $1.92bn
- $5.46bn
- $5.78bn
- 37
- 74
- 55
- 57
Annual balance sheet for Chemours Co, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 1,105 | 1,451 | 1,102 | 1,203 | 713 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 511 | 720 | 626 | 610 | 770 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 2,633 | 3,345 | 3,214 | 3,835 | 3,026 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 3,710 | 3,381 | 3,411 | 3,476 | 3,441 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 7,082 | 7,550 | 7,640 | 8,251 | 7,515 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 1,442 | 1,858 | 1,891 | 2,486 | 1,803 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 6,269 | 6,469 | 6,533 | 7,514 | 6,911 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Other Equity | |||||
| Total Equity | 813 | 1,081 | 1,107 | 737 | 604 |
| Total Liabilities & Shareholders' Equity | 7,082 | 7,550 | 7,640 | 8,251 | 7,515 |
| Total Common Shares Outstanding |